EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microbial assimilatory sulfate reduction-mediated H2S: an overlooked role in Crohn’s disease development

Wanrong Luo, Min Zhao, Mohammed Dwidar, Yang Gao, Liyuan Xiang, Xueting Wu, Marnix H Medema, Shu Xu, Xiaozhi Li, Hendrik Schäfer, Minhu Chen, Rui Feng und 1 weitere

Microbiome · 16.08.2024 · 12 (1)

DOI: 10.1186/s40168-024-01873-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiome, online erschienen am 16.08.2024. Verfasst von Wanrong Luo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the First Affiliated Hospital, Sun Yat-Sen University, No.58 Zhongshan Er Road, Room 1209, Guangzhou, 510080, China. Hauptthemen laut MEDLINE: Crohn Disease, Gastrointestinal Microbiome, Hydrogen Sulfide, Sulfates. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Zhuang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

H 2 S imbalances in the intestinal tract trigger Crohn's disease (CD), a chronic inflammatory gastrointestinal disorder characterized by microbiota dysbiosis and barrier dysfunction. However, a comprehensive understanding of H 2 S generation in the gut, and the contributions of both microbiota and host to systemic H 2 S levels in CD, remain to be elucidated. This investigation aimed to enhance comprehension regarding the sulfidogenic potential of both the human host and the gut microbiota.

Results

Our analysis of a treatment-naive CD cohorts' fecal metagenomic and biopsy metatranscriptomic data revealed reduced expression of host endogenous H 2 S generation genes alongside increased abundance of microbial exogenous H 2 S production genes in correlation with CD. While prior studies focused on microbial H 2 S production via dissimilatory sulfite reductases, our metagenomic analysis suggests the assimilatory sulfate reduction (ASR) pathway is a more significant contributor in the human gut, given its high prevalence and abundance. Subsequently, we validated our hypothesis experimentally by generating ASR-deficient E. coli mutants ∆cysJ and ∆cysM through the deletion of sulfite reductase and L-cysteine synthase genes. This alteration significantly affected bacterial sulfidogenic capacity, colon epithelial cell viability, and colonic mucin sulfation, ultimately leading to colitis in murine model. Further study revealed that gut microbiota degrade sulfopolysaccharides and assimilate sulfate to produce H 2 S via the ASR pathway, highlighting the role of sulfopolysaccharides in colitis and cautioning against their use as food additives.

Conclusions

Our study significantly advances understanding of microbial sulfur metabolism in the human gut, elucidating the complex interplay between diet, gut microbiota, and host sulfur metabolism. We highlight the microbial ASR pathway as an overlooked endogenous H 2 S producer and a potential therapeutic target for managing CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseGastrointestinal MicrobiomeHydrogen SulfideSulfatesHumansAnimalsMiceEscherichia coliFecesDysbiosisColonMetagenomicsOxidation-ReductionDisease Models, AnimalFemale

Stichwörter der Autor:innen

3’-Phosphoadenosine-5’-Phosphosulfate PAPSAdenosine-5’-Phosphosulfate APSInflammatory bowel diseaseInorganic sulfateSulfopolysaccharide

Substanzen

Hydrogen SulfideSulfates

Autor:innen und Institutionen

  • Department of Gastroenterology, the First Affiliated Hospital, Sun Yat-Sen University, No.58 Zhongshan Er Road, Room 1209, Guangzhou, 510080, China.
  • Institute of Precision Medicine, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Department of Gastroenterology, Shenzhen No.3 People's Hospital, Shenzhen, Guangdong, China.
  • Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Center for Microbiome and Human Health, Cleveland Clinic, Cleveland, OH, USA.
  • Bioinformatics Group, Wageningen University, Wageningen, The Netherlands.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Luo, W., Zhao, M., Dwidar, M., Gao, Y., Xiang, L., Wu, X., Medema, M. H., Xu, S., Li, X., Schäfer, H., Chen, M., Feng, R., & Zhu, Y. (2024). Microbial assimilatory sulfate reduction-mediated H2S: an overlooked role in Crohn’s disease development. Microbiome, 12(1). https://doi.org/10.1186/s40168-024-01873-2

Vancouver

Luo W, Zhao M, Dwidar M, Gao Y, Xiang L, Wu X, et al. Microbial assimilatory sulfate reduction-mediated H2S: an overlooked role in Crohn’s disease development. Microbiome. 2024;12(1). doi:10.1186/s40168-024-01873-2

BibTeX
@article{Luo2024,
  author = {Luo, Wanrong and Zhao, Min and Dwidar, Mohammed and Gao, Yang and Xiang, Liyuan and Wu, Xueting and Medema, Marnix H and Xu, Shu and Li, Xiaozhi and Schäfer, Hendrik and Chen, Minhu and Feng, Rui and Zhu, Yijun},
  title = {Microbial assimilatory sulfate reduction-mediated H2S: an overlooked role in Crohn’s disease development},
  journal = {Microbiome},
  year = {2024},
  volume = {12},
  number = {1},
  doi = {10.1186/s40168-024-01873-2}
}
Kostenlos starten →